Embedded in the colonic mucus are cathelicidins, small cationic peptides secreted by colonic epithelial cells. Humans and mice have one cathelicidin-related antimicrobial peptide (CRAMP) each, LL-37/hCAP-18 and Cramp, respectively, with related structure and functions. Altered production of MUC2 mucin and antimicrobial peptides is characteristic of intestinal amebiasis. The interactions between MUC2 mucin and cathelicidins in conferring innate immunity against Entamoeba histolytica are not well characterized. In this study, we quantified whether MUC2 expression and release could regulate the expression and secretion of cathelicidin LL-37 in colonic epithelial cells and in the colon. The synthesis of LL-37 was enhanced with butyrate (a product of bacterial fermentation) and interleukin-1 (IL-1) (a proinflammatory cytokine in colitis) in the presence of exogenously added purified MUC2. The LL-37 responses to butyrate and IL-1 were higher in high-MUC2-producing cells than in lentivirus short hairpin RNA (shRNA) MUC2-silenced cells. Activation of cyclic adenylyl cyclase (AMP) and mitogen-activated protein kinase (MAPK) signaling pathways was necessary for the simultaneous expression of MUC2 and cathelicidins. In Muc2 mucin-deficient (Muc2 Ϫ/Ϫ ) mice, murine cathelicidin (Cramp) was significantly reduced compared to that in Muc2 ϩ/Ϫ and Muc2 ϩ/ϩ littermates. E. histolyticainduced acute inflammation in colonic loops stimulated high levels of cathelicidin in Muc2 ϩ/ϩ but not in Muc2 Ϫ/Ϫ littermates. In dextran sodium sulfate (DSS)-induced colitis in Muc2 ϩ/ϩ mice, which depletes the mucus barrier and goblet cell mucin, Cramp expression was significantly enhanced during restitution. These studies demonstrate regulatory mechanisms between MUC2 and cathelicidins in the colonic mucosa where an intact mucus barrier is essential for expression and secretion of cathelicidins in response to E. histolytica-and DSS-induced colitis.
KEYWORDS Entamoeba histolytica, MUC2, antimicrobial peptides, mucinT he innate defenses of the colon and first barrier against pathogens include glycosylated MUC2 mucin secreted by goblet cells that forms an inner sterile layer firmly attached to the epithelium and an outer layer with an expanded volume and that is colonized by bacteria (1). Embedded in colonic mucus are cathelicidins, small cationic peptides (23 to 37 amino acids) secreted by neutrophils and epithelial cells, including colonic epithelium, with broad antimicrobial activity (2, 3). The only cathelicidin described in humans is LL-37/hCAP-18, which is homologous to mouse cathelicidinrelated antimicrobial peptide (CRAMP) (2, 3). Both LL-37 and CRAMP have related structure and antimicrobial and chemotactic functions (2, 3). Sodium butyrate pro-